Skip to main content
# Title Department Research Year
371 Latanoprost niosomes as a sustained release ocular delivery system for the
management of glaucoma
Department of Pharmaceutics 2020
372 Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations Department of Pharmaceutics 2020
373 Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19 Department of Pharmaceutics 2020
374 Design and synthesis of some 1,3,5-tri-substituted oxindole derivatives as potential CDK inhibitors Department of Medicinal Chemistry 2020
375 Antimicrobial Pyridazines: Synthesis, Characterization, Cytotoxicity, Substrate Promiscuity, and Molecular Docking Department of Pharmaceutical Organic Chemistry 2020
376 Severe cutaneous adverse drug reactions: Incidence, Clinical Patterns, Causative Drugs and Modalities of Treatment in Assiut University Hospital, Upper Egypt 2020
377 Novel Sponge-Like Mn5O8 Nanoparticles Deposited on Graphite Electrode for Electrochemical Study of Hepatitis C Antiviral Drug, Elbasvir 2020
378 Epigallocatechin-3-Gallate-Loaded Gold
Nanoparticles: Preparation and Evaluation of
Anticancer Efficacy in Ehrlich Tumor-Bearing Mice
Department of Pharmaceutics 2020
379 Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation Department of Pharmaceutical Organic Chemistry 2020
380 Design, Synthesis, and biological evaluation of new series of pyrrol-2(3H)-one and pyridazin-3(2H)-one derivatives as tubulin polymerization inhibitors Department of Pharmaceutical Organic Chemistry 2020